Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor
- PMID: 19143636
- DOI: 10.1042/BST0370223
Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor
Abstract
The signalling function of mTOR complex 1 is activated by Rheb-GTP, which controls the catalytic competence of the mTOR (mammalian target of rapamycin) kinase domain by an incompletely understood mechanism. Rheb can bind directly to the mTOR kinase domain, and association with inactive nucleotide-deficient Rheb mutants traps mTOR in a catalytically inactive state. Nevertheless, Rheb-GTP targets other than mTOR, such as FKBP38 (FK506-binding protein 38) and/or PLD1 (phospholipase D(1)), may also contribute to mTOR activation. Once activated, the mTOR catalytic domain phosphorylates substrates only when they are bound to raptor (regulatory associated protein of mTOR), a separate polypeptide within the complex. The mechanism of insulin/nutrient stimulation of mTOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide. The mechanism underlying this second step in the activation of mTORC1 is unknown.
Similar articles
-
Rheb binds and regulates the mTOR kinase.Curr Biol. 2005 Apr 26;15(8):702-13. doi: 10.1016/j.cub.2005.02.053. Curr Biol. 2005. PMID: 15854902
-
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.Oncogene. 2006 Oct 16;25(48):6361-72. doi: 10.1038/sj.onc.1209882. Oncogene. 2006. PMID: 17041622 Review.
-
An autoinhibited noncanonical mechanism of GTP hydrolysis by Rheb maintains mTORC1 homeostasis.Structure. 2012 Sep 5;20(9):1528-39. doi: 10.1016/j.str.2012.06.013. Epub 2012 Jul 19. Structure. 2012. PMID: 22819219
-
Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1.FEBS Lett. 2005 Aug 29;579(21):4763-8. doi: 10.1016/j.febslet.2005.07.054. FEBS Lett. 2005. PMID: 16098514
-
Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates.F1000Res. 2019 Jan 3;8:F1000 Faculty Rev-14. doi: 10.12688/f1000research.16109.1. eCollection 2019. F1000Res. 2019. PMID: 30647914 Free PMC article. Review.
Cited by
-
Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition.J Neuroinflammation. 2023 Sep 5;20(1):202. doi: 10.1186/s12974-023-02886-8. J Neuroinflammation. 2023. PMID: 37670386 Free PMC article.
-
Natural compounds from botanical drugs targeting mTOR signaling pathway as promising therapeutics for atherosclerosis: A review.Front Pharmacol. 2023 Jan 20;14:1083875. doi: 10.3389/fphar.2023.1083875. eCollection 2023. Front Pharmacol. 2023. PMID: 36744254 Free PMC article. Review.
-
Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of Tsc2-Null Cells.Front Pharmacol. 2022 Jun 23;13:912688. doi: 10.3389/fphar.2022.912688. eCollection 2022. Front Pharmacol. 2022. PMID: 35814251 Free PMC article.
-
Ras, PI3K and mTORC2 - three's a crowd?J Cell Sci. 2020 Oct 8;133(19):jcs234930. doi: 10.1242/jcs.234930. J Cell Sci. 2020. PMID: 33033115 Free PMC article. Review.
-
Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability.Cells. 2020 Aug 31;9(9):1998. doi: 10.3390/cells9091998. Cells. 2020. PMID: 32878021 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous